Quarterly report pursuant to Section 13 or 15(d)

Basis of Presentation and Summary of Significant Accounting Policies (Tables)

v3.23.1
Basis of Presentation and Summary of Significant Accounting Policies (Tables)
3 Months Ended
Mar. 31, 2023
Basis of Presentation and Summary of Significant Accounting Policies (Tables) LineItems  
Schedule of reconciliation of the components of cash and restricted cash
    March 31,  
(in thousands)   2023     2022  
Cash and cash equivalents   $ 19,914     $ 36,652  
Restricted cash     125       125  
Restricted cash – noncurrent     600       207  
Total cash, cash equivalents and restricted cash presented in the condensed consolidated statements of cash flows   $ 20,639     $ 36,984  

 

Schedule of liability deferred revenue
(in thousands   Three
Months Ended
March 31,
2023
    Year
Ended
December 31,
2022
 
Balance, beginning of period   $ 7,254     $ 6,238  
Deferral of revenue     9,289       31,949  
Recognition of unearned revenue     (9,628 )     (30,933 )
Balance, end of period   $ 6,915     $ 7,254  

 

Schedule of diluted weighted-average shares of common stock outstanding
    March 31,
2023
    March 31,
2022
 
Common stock warrants     2,801,703       2,753,408  
Stock options     9,477,307       8,094,544  
Restricted stock units     263,155        
      12,542,165       10,847,952